For teams developing injectable biologics and high volume drugs up to 50 mL, new, advanced wearable delivery technology automates lyophilization and makes development of stable, bioavailable, clinically relevant formulations easier, faster, and less costly.
For teams developing injectable biologics and high volume drugs up to 50 mL, new, advanced wearable delivery technology automates lyophilization and makes development of stable, bioavailable, clinically relevant formulations easier, faster, and less costly.